Determination of the exocrine pancreatic function with the NBT-PABA test using a novel dual isotope technique and gas chromatography-mass spectrometry

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 57, Issue 2, 1997, Pages 159-165

  Larsen, B ^a   Ekelund, S ^a   Jorgensen L ^a   Bremmelgaard, A ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

4 aminobenzoic acid; bentiromide; gas chromatography; mass fragmentography; pancreatic diseases; pancreatic function tests; pancreatic insufficiency; stable isotopes

Indexed keywords

BENTIROMIDE; CARBON 13; CHYMOTRYPSIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME SUBSTRATE; FUNCTION TEST; GAS CHROMATOGRAPHY; HUMAN; ISOTOPE LABELING; MASS SPECTROMETRY; PANCREAS FUNCTION; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL;

EID: 0031007263     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365519709056384     Document Type: Article

References (15)

1. Lankisch PG. Function tests in the diagnosis of chronic pancreatitis. Int J Pancreatol 1993; 14: 9-20.
2. Imondi AR, Stradley RP, Wolgemuth R. Synthetic peptides in the diagnosis of exocrine pancreatic insufficiency in animals. Gut 1972; 13: 726-31.
3. Gyr K, Stalder GA, Schiffmann I, Fehr D, Vonderschmitt D, Fahrlaender H. Oral administration of a chymotrypsin-labile peptide - a new test of exocrine pancreatic function in man (PFT). Gut 1976; 17: 27-32.
4. Arvanitakis C, Greenberger NJ. Diagnosis of pancreatic disease by a synthetic peptide. Lancet 1976; i: 663-6.
5. Mitchell CJ, Humphrey CS, Bullen AW, Kelleher J, Losowsky MS. Improved diagnostic accuracy of a modified oral pancreatic function test. Scand J Gastroenterol 1979; 14: 737-41.
6. Tetlow VA, Lobley RW, Herman K, Braganza JM. A one-day oral pancreatic function test using a chymotrypsin-labile peptide and a radioactive marker. Clin Trials J 1980; 17: 121-30.
7. Berg JD, Chesner IM, Allen-Narker RAC, Buckley BM, Lawson N. Exocrine pancreatic function as determined in a same-day test with use of bentiromide and p-aminosalicylic acid. Clin Chem 1986; 32: 1010-12.
8. Hoek FJ, Van den Bergh FAJTM, Klein Elhorst JT, Meijer JL, Timmer E, Tytgat GNJ. Improved specificity of the PABA test with p-aminosalicylic acid (PAS). Gut 1987; 28: 468-73.
9. Delchier J-C, Soule J-C. BT-PABA test with plasma PABA measurements: evaluation of sensitivity and specificity. Gut 1983; 24: 318-25.
10. Lang C, Gyr K, Tonko I, Conen D, Stalder GA. Value of serum PABA as a pancreatic function test. Gut 1984; 25: 508-12.
11. Ito S, Maruta K, Imai Y, Kato T, Ito M, Nakajima S, et al. Urinary p-aminobenzoic acid determined in the pancreatic function test by liquid chromotography, with electrochemical detection. Clin Chem 1982; 28: 323-6.
12. Hung CT, Perrier DG, Schicker AM, Zoest AR. Analysis of p-aminobenzoic acid and its metabolites in urine and plasma by ion pair HPLC in the NBT-PABA pancreatic function test. Biomed Chromatogr 1987; 2: 13-16.
13. Berg JD, Chesner I, Lawson N. Practical assessment of the NBT-PABA pancreatic function test using high performance liquid chromatography determination of p-aminobenzoic acid in urine. Ann Clin Biochem 1985; 22: 586-90.
14. Braden B, Lembcke B, Caspary WF. Stabile isotope in diagnostik und forschung [Review] Dtsch Med Wschr 1991; 116: 1721-17.
15. Deutsch JC, Santhosh-Kumar CR, Kolli VR. A noninvasive stable-isotope method to simultaneously assess pancreatic exocrine function and small bowel absorption. Am J Gastroenterol 1995; 90: 2182-5.